Anti-GLB1 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22081; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our highly efficient Anti-GLB1 Polyclonal Antibody, a powerful tool for your biotech research needs. This antibody is specifically designed to target the GLB1 protein, an essential enzyme involved in the breakdown of complex carbohydrates.
The GLB1 protein plays a crucial role in lysosomal storage diseases, such as GM1 gangliosidosis and Morquio B syndrome. These diseases are characterized by the accumulation of glycolipids in various tissues, leading to severe neurological and skeletal defects. By targeting GLB1, our antibody can aid in the study of these diseases and potentially lead to the development of new treatments.
With its high specificity and sensitivity, our Anti-GLB1 Polyclonal Antibody is ideal for a variety of applications. It can be used in Western blotting, immunohistochemistry, and ELISA assays to detect and quantify GLB1 protein levels in various samples. This antibody has been extensively tested and validated, ensuring reliable and reproducible results.
In addition to its main applications, our Anti-GLB1 Polyclonal Antibody has also been successfully used in experimental studies. It has been shown to effectively inhibit GLB1 activity in cell culture, providing valuable insights into the protein’s function and potential therapeutic targets.
Furthermore, our antibody is produced using state-of-the-art technology and undergoes rigorous quality control measures to ensure purity and consistency. It is available in various sizes to suit your specific research needs.
In summary, our Anti-GLB1 Polyclonal Antibody is a top-of-the-line product that offers exceptional performance and reliability for your biotech research. With its ability to target GLB1 and its various applications and experimental uses, this antibody is a valuable asset for studying lysosomal storage diseases and advancing scientific knowledge. Trust in our Anti-GLB1 Polyclonal Antibody to provide accurate and meaningful results for your research. Order now and take your biotech research to the next level.
ProteoGenix catalogue number ARO-A22081. For research use only.
Target: Beta-galactosidase; 3.2.1.23; Acid beta-galactosidase; Lactase; Elastin receptor 1; GLB1; ELNR1; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Beta-galactosidase; 3.2.1.23; Acid beta-galactosidase; Lactase; Elastin receptor 1; GLB1; ELNR1 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
